@ARTICLE{Ventham2016-qj,
  title    = "Integrative epigenome-wide analysis demonstrates that {DNA}
              methylation may mediate genetic risk in inflammatory bowel
              disease",
  author   = "Ventham, N T and Kennedy, N A and Adams, A T and Kalla, R and
              Heath, S and O'Leary, K R and Drummond, H and {IBD BIOM
              consortium} and {IBD CHARACTER consortium} and Wilson, D C and
              Gut, I G and Nimmo, E R and Satsangi, J",
  abstract = "Epigenetic alterations may provide important insights into
              gene-environment interaction in inflammatory bowel disease (IBD).
              Here we observe epigenome-wide DNA methylation differences in 240
              newly-diagnosed IBD cases and 190 controls. These include 439
              differentially methylated positions (DMPs) and 5 differentially
              methylated regions (DMRs), which we study in detail using whole
              genome bisulphite sequencing. We replicate the top DMP (RPS6KA2)
              and DMRs (VMP1, ITGB2 and TXK) in an independent cohort. Using
              paired genetic and epigenetic data, we delineate methylation
              quantitative trait loci; VMP1/microRNA-21 methylation associates
              with two polymorphisms in linkage disequilibrium with a known IBD
              susceptibility variant. Separated cell data shows that
              IBD-associated hypermethylation within the TXK promoter region
              negatively correlates with gene expression in whole-blood and
              CD8+ T cells, but not other cell types. Thus, site-specific DNA
              methylation changes in IBD relate to underlying genotype and
              associate with cell-specific alteration in gene expression.",
  journal  = "Nat. Commun.",
  volume   =  7,
  pages    = "13507",
  month    =  nov,
  year     =  2016,
  language = "en"
}

@MISC{Zhang2019-br,
  title   = "Improved precision of epigenetic clock estimates across tissues
             and its implication for biological ageing",
  author  = "Zhang, Qian and Vallerga, Costanza L and Walker, Rosie M and Lin,
             Tian and Henders, Anjali K and Montgomery, Grant W and He, Ji and
             Fan, Dongsheng and Fowdar, Javed and Kennedy, Martin and Pitcher,
             Toni and Pearson, John and Halliday, Glenda and Kwok, John B and
             Hickie, Ian and Lewis, Simon and Anderson, Tim and Silburn, Peter
             A and Mellick, George D and Harris, Sarah E and Redmond, Paul and
             Murray, Alison D and Porteous, David J and Haley, Christopher S
             and Evans, Kathryn L and McIntosh, Andrew M and Yang, Jian and
             Gratten, Jacob and Marioni, Riccardo E and Wray, Naomi R and
             Deary, Ian J and McRae, Allan F and Visscher, Peter M",
  journal = "Genome Medicine",
  volume  =  11,
  number  =  1,
  year    =  2019
}

@ARTICLE{Thompson2017-cl,
  title    = "An epigenetic aging clock for dogs and wolves",
  author   = "Thompson, Michael J and vonHoldt, Bridgett and Horvath, Steve and
              Pellegrini, Matteo",
  abstract = "Several articles describe highly accurate age estimation methods
              based on human DNA-methylation data. It is not yet known whether
              similar epigenetic aging clocks can be developed based on blood
              methylation data from canids. Using Reduced Representation
              Bisulfite Sequencing, we assessed blood DNA-methylation data from
              46 domesticated dogs (Canis familiaris) and 62 wild gray wolves
              (C. lupus). By regressing chronological dog age on the resulting
              CpGs, we defined highly accurate multivariate age estimators for
              dogs (based on 41 CpGs), wolves (67 CpGs), and both combined (115
              CpGs). Age related DNA methylation changes in canids implicate
              similar gene ontology categories as those observed in humans
              suggesting an evolutionarily conserved mechanism underlying
              age-related DNA methylation in mammals.",
  journal  = "Aging",
  volume   =  9,
  number   =  3,
  pages    = "1055--1068",
  month    =  mar,
  year     =  2017,
  keywords = "DNA methylation; biological age; canine; dog; epigenetic clock;
              wolf",
  language = "en"
}

@ARTICLE{Frey2007-mu,
  title    = "Clustering by passing messages between data points",
  author   = "Frey, Brendan J and Dueck, Delbert",
  abstract = "Clustering data by identifying a subset of representative
              examples is important for processing sensory signals and
              detecting patterns in data. Such ``exemplars'' can be found by
              randomly choosing an initial subset of data points and then
              iteratively refining it, but this works well only if that initial
              choice is close to a good solution. We devised a method called
              ``affinity propagation,'' which takes as input measures of
              similarity between pairs of data points. Real-valued messages are
              exchanged between data points until a high-quality set of
              exemplars and corresponding clusters gradually emerges. We used
              affinity propagation to cluster images of faces, detect genes in
              microarray data, identify representative sentences in this
              manuscript, and identify cities that are efficiently accessed by
              airline travel. Affinity propagation found clusters with much
              lower error than other methods, and it did so in less than
              one-hundredth the amount of time.",
  journal  = "Science",
  volume   =  315,
  number   =  5814,
  pages    = "972--976",
  month    =  feb,
  year     =  2007,
  language = "en"
}

@ARTICLE{Harris2020-yb,
  title    = "Array programming with {NumPy}",
  author   = "Harris, Charles R and Millman, K Jarrod and van der Walt,
              St{\'e}fan J and Gommers, Ralf and Virtanen, Pauli and
              Cournapeau, David and Wieser, Eric and Taylor, Julian and Berg,
              Sebastian and Smith, Nathaniel J and Kern, Robert and Picus,
              Matti and Hoyer, Stephan and van Kerkwijk, Marten H and Brett,
              Matthew and Haldane, Allan and Del R{\'\i}o, Jaime Fern{\'a}ndez
              and Wiebe, Mark and Peterson, Pearu and G{\'e}rard-Marchant,
              Pierre and Sheppard, Kevin and Reddy, Tyler and Weckesser, Warren
              and Abbasi, Hameer and Gohlke, Christoph and Oliphant, Travis E",
  abstract = "Array programming provides a powerful, compact and expressive
              syntax for accessing, manipulating and operating on data in
              vectors, matrices and higher-dimensional arrays. NumPy is the
              primary array programming library for the Python language. It has
              an essential role in research analysis pipelines in fields as
              diverse as physics, chemistry, astronomy, geoscience, biology,
              psychology, materials science, engineering, finance and
              economics. For example, in astronomy, NumPy was an important part
              of the software stack used in the discovery of gravitational
              waves1 and in the first imaging of a black hole2. Here we review
              how a few fundamental array concepts lead to a simple and
              powerful programming paradigm for organizing, exploring and
              analysing scientific data. NumPy is the foundation upon which the
              scientific Python ecosystem is constructed. It is so pervasive
              that several projects, targeting audiences with specialized
              needs, have developed their own NumPy-like interfaces and array
              objects. Owing to its central position in the ecosystem, NumPy
              increasingly acts as an interoperability layer between such array
              computation libraries and, together with its application
              programming interface (API), provides a flexible framework to
              support the next decade of scientific and industrial analysis.",
  journal  = "Nature",
  volume   =  585,
  number   =  7825,
  pages    = "357--362",
  month    =  sep,
  year     =  2020,
  language = "en"
}

@ARTICLE{Terrell2016-yw,
  title    = "Breast cancer among women in Michigan following exposure to
              brominated flame retardants",
  author   = "Terrell, Metrecia L and Rosenblatt, Karin A and Wirth, Julie and
              Cameron, Lorraine L and Marcus, Michele",
  abstract = "In this updated follow-up, we investigated the breast cancer
              experience among women in Michigan exposed to brominated flame
              retardants, some 30 years following exposure. Michigan residents
              were enrolled in a study cohort after exposure to polybrominated
              biphenyls (PBBs) through the consumption of contaminated food
              products. PBB concentrations were measured in serum at the time
              of enrolment. Cancer experience was determined by linkage to the
              Michigan Cancer Registry. We conducted a nested case-control
              study that included 51 women diagnosed with breast cancer during
              1974-2004 and 202 age-matched controls. While the data suggest an
              increase in breast cancer risk with higher PBB exposure, this did
              not reach statistical significance. The OR of having breast
              cancer among women with PBB concentrations $\geq$10 ng/mL
              compared to women with PBB concentrations at or below the limit
              of detection of 1 ng/mL was 2.60, 95\% CI 0.93 to 7.27, (p=0.07),
              when adjusted for age and family history of cancer in a
              first-degree female relative. It remains important to examine
              exposure to brominated chemicals and possible health effects, and
              to continue following the cancer experience of participants in
              this study.",
  journal  = "Occup. Environ. Med.",
  volume   =  73,
  number   =  8,
  pages    = "564--567",
  month    =  aug,
  year     =  2016,
  language = "en"
}

@ARTICLE{Thompson2018-rh,
  title    = "A multi-tissue full lifespan epigenetic clock for mice",
  author   = "Thompson, Michael J and Chwia{\l}kowska, Karolina and Rubbi,
              Liudmilla and Lusis, Aldons J and Davis, Richard C and
              Srivastava, Anuj and Korstanje, Ron and Churchill, Gary A and
              Horvath, Steve and Pellegrini, Matteo",
  abstract = "Human DNA-methylation data have been used to develop highly
              accurate biomarkers of aging (``epigenetic clocks''). Recent
              studies demonstrate that similar epigenetic clocks for mice (Mus
              Musculus) can be slowed by gold standard anti-aging interventions
              such as calorie restriction and growth hormone receptor
              knock-outs. Using DNA methylation data from previous publications
              with data collected in house for a total 1189 samples spanning
              193,651 CpG sites, we developed 4 novel epigenetic clocks by
              choosing different regression models (elastic net- versus ridge
              regression) and by considering different sets of CpGs (all CpGs
              vs highly conserved CpGs). We demonstrate that accurate age
              estimators can be built on the basis of highly conserved CpGs.
              However, the most accurate clock results from applying elastic
              net regression to all CpGs. While the anti-aging effect of
              calorie restriction could be detected with all types of
              epigenetic clocks, only ridge regression based clocks replicated
              the finding of slow epigenetic aging effects in dwarf mice.
              Overall, this study demonstrates that there are trade-offs when
              it comes to epigenetic clocks in mice. Highly accurate clocks
              might not be optimal for detecting the beneficial effects of
              anti-aging interventions.",
  journal  = "Aging",
  volume   =  10,
  number   =  10,
  pages    = "2832--2854",
  month    =  oct,
  year     =  2018,
  keywords = "DNA methylation; biological age; epigenetic clock; mouse",
  language = "en"
}

@MISC{Kurushima2019-gc,
  title   = "Epigenetic findings in periodontitis in {UK} twins: a
             cross-sectional study",
  author  = "Kurushima, Yuko and Tsai, Pei-Chien and Castillo-Fernandez, Juan
             and Alves, Alexessander Couto and Moustafa, Julia Sarah El-Sayed
             and Le Roy, Caroline and Spector, Tim D and Ide, Mark and Hughes,
             Francis J and Small, Kerrin S and Steves, Claire J and Bell,
             Jordana T",
  journal = "Clinical Epigenetics",
  volume  =  11,
  number  =  1,
  year    =  2019
}

@MISC{Horvath2013-sk,
  title   = "{DNA} methylation age of human tissues and cell types",
  author  = "Horvath, Steve",
  journal = "Genome Biology",
  volume  =  14,
  number  =  10,
  pages   = "R115",
  year    =  2013
}

@ARTICLE{Tserel2015-qr,
  title    = "Age-related profiling of {DNA} methylation in {CD8+} {T} cells
              reveals changes in immune response and transcriptional regulator
              genes",
  author   = "Tserel, Liina and Kolde, Raivo and Limbach, Maia and Tretyakov,
              Konstantin and Kasela, Silva and Kisand, Kai and Saare, Mario and
              Vilo, Jaak and Metspalu, Andres and Milani, Lili and Peterson,
              P{\"a}rt",
  abstract = "Human ageing affects the immune system resulting in an overall
              decline in immunocompetence. Although all immune cells are
              affected during aging, the functional capacity of T cells is most
              influenced and is linked to decreased responsiveness to
              infections and impaired differentiation. We studied age-related
              changes in DNA methylation and gene expression in CD4+ and CD8+ T
              cells from younger and older individuals. We observed marked
              difference between T cell subsets, with increased number of
              methylation changes and higher methylome variation in CD8+ T
              cells with age. The majority of age-related hypermethylated sites
              were located at CpG islands of silent genes and enriched for
              repressive histone marks. Specifically, in CD8+ T cell subset we
              identified strong inverse correlation between methylation and
              expression levels in genes associated with T cell mediated immune
              response (LGALS1, IFNG, CCL5, GZMH, CCR7, CD27 and CD248) and
              differentiation (SATB1, TCF7, BCL11B and RUNX3). Our results thus
              suggest the link between age-related epigenetic changes and
              impaired T cell function.",
  journal  = "Sci. Rep.",
  volume   =  5,
  pages    = "13107",
  month    =  aug,
  year     =  2015,
  language = "en"
}

@MISC{Jacobson2017-yi,
  title   = "Serum Polybrominated Biphenyls ({PBBs}) and Polychlorinated
             Biphenyls ({PCBs}) and Thyroid Function among Michigan Adults
             Several Decades after the 1973--1974 {PBB} Contamination of
             Livestock Feed",
  author  = "Jacobson, Melanie H and Darrow, Lyndsey A and Barr, Dana Boyd and
             Howards, Penelope P and Lyles, Robert H and Terrell, Metrecia L
             and Smith, Alicia K and Conneely, Karen N and Elizabeth Marder, M
             and Marcus, Michele",
  journal = "Environmental Health Perspectives",
  volume  =  125,
  number  =  9,
  pages   = "097020",
  year    =  2017
}

@MISC{Basu_undated-vq,
  title   = "Reproducible research with jupyter notebooks",
  author  = "Basu, Arindam",
  journal = "Authorea"
}

@ARTICLE{Barrett2012-gu,
  title     = "{NCBI} {GEO}: archive for functional genomics data sets---update",
  author    = "Barrett, Tanya and Wilhite, Stephen E and Ledoux, Pierre and
               Evangelista, Carlos and Kim, Irene F and Tomashevsky, Maxim and
               Marshall, Kimberly A and Phillippy, Katherine H and Sherman,
               Patti M and Holko, Michelle and Yefanov, Andrey and Lee,
               Hyeseung and Zhang, Naigong and Robertson, Cynthia L and Serova,
               Nadezhda and Davis, Sean and Soboleva, Alexandra",
  abstract  = "Abstract. The Gene Expression Omnibus (GEO,
               http://www.ncbi.nlm.nih.gov/geo/) is an international public
               repository for high-throughput microarray and next-gene",
  journal   = "Nucleic Acids Res.",
  publisher = "Oxford Academic",
  volume    =  41,
  number    = "D1",
  pages     = "D991--D995",
  month     =  nov,
  year      =  2012,
  keywords  = "internet",
  language  = "en"
}

@INPROCEEDINGS{Seabold2010-lt,
  title       = "Statsmodels: Econometric and statistical modeling with python",
  booktitle   = "Proceedings of the 9th Python in Science Conference",
  author      = "Seabold, Skipper and Perktold, Josef",
  volume      =  57,
  pages       = "61",
  institution = "Austin, TX",
  year        =  2010
}

@ARTICLE{Farrell2020-ri,
  title    = "The Epigenetic Pacemaker: modeling epigenetic states under an
              evolutionary framework",
  author   = "Farrell, Colin and Snir, Sagi and Pellegrini, Matteo",
  abstract = "SUMMARY: Epigenetic rates of change, much as evolutionary
              mutation rate along a lineage, vary during lifetime. Accurate
              estimation of the epigenetic state has vast medical and
              biological implications. To account for these non-linear
              epigenetic changes with age, we recently developed a formalism
              inspired by the Pacemaker model of evolution that accounts for
              varying rates of mutations with time. Here, we present a python
              implementation of the Epigenetic Pacemaker (EPM), a conditional
              expectation maximization algorithm that estimates epigenetic
              landscapes and the state of individuals and may be used to study
              non-linear epigenetic aging. AVAILABILITY AND IMPLEMENTATION: The
              EPM is available at https://pypi.org/project/EpigeneticPacemaker/
              under the MIT license. The EPM is compatible with python version
              3.6 and above.",
  journal  = "Bioinformatics",
  volume   =  36,
  number   =  17,
  pages    = "4662--4663",
  month    =  nov,
  year     =  2020,
  language = "en"
}

@ARTICLE{Curtis2019-mv,
  title    = "Thyroid hormone levels associate with exposure to polychlorinated
              biphenyls and polybrominated biphenyls in adults exposed as
              children",
  author   = "Curtis, Sarah W and Terrell, Metrecia L and Jacobson, Melanie H
              and Cobb, Dawayland O and Jiang, Victoria S and Neblett, Michael
              F and Gerkowicz, Sabrina A and Spencer, Jessica B and Marder, M
              Elizabeth and Barr, Dana Boyd and Conneely, Karen N and Smith,
              Alicia K and Marcus, Michele",
  abstract = "BACKGROUND: Michigan residents were directly exposed to
              endocrine-disrupting compounds, polybrominated biphenyl (PBB) and
              polychlorinated biphenyl (PCB). A growing body of evidence
              suggests that exposure to certain endocrine-disrupting compounds
              may affect thyroid function, especially in people exposed as
              children, but there are conflicting observations. In this study,
              we extend previous work by examining age of exposure's effect on
              the relationship between PBB exposure and thyroid function in a
              large group of individuals exposed to PBB. METHODS: Linear
              regression models were used to test the association between serum
              measures of thyroid function (total thyroxine (T4), total
              triiodothyronine (T3), free T4, free T3, thyroid stimulating
              hormone (TSH), and free T3: free T4 ratio) and serum PBB and PCB
              levels in a cross-sectional analysis of 715 participants in the
              Michigan PBB Registry. RESULTS: Higher PBB levels were associated
              with many thyroid hormones measures, including higher free T3 (p
              = 0.002), lower free T4 (p = 0.01), and higher free T3: free T4
              ratio (p = 0.0001). Higher PCB levels were associated with higher
              free T4 (p = 0.0002), and higher free T3: free T4 ratio (p =
              0.002). Importantly, the association between PBB and thyroid
              hormones was dependent on age at exposure. Among people exposed
              before age 16 (N = 446), higher PBB exposure was associated with
              higher total T3 (p = 0.01) and free T3 (p = 0.0003), lower free
              T4 (p = 0.04), and higher free T3: free T4 ratio (p = 0.0001). No
              significant associations were found among participants who were
              exposed after age 16. No significant associations were found
              between TSH and PBB or PCB in any of the analyses conducted.
              CONCLUSIONS: This suggests that both PBB and PCB are associated
              with thyroid function, particularly among those who were exposed
              as children or prenatally.",
  journal  = "Environ. Health",
  volume   =  18,
  number   =  1,
  pages    = "75",
  month    =  aug,
  year     =  2019,
  keywords = "Age at exposure; Children's health; DOHaD; EDC; Endocrine
              disrupting compound; PBB; PCB; Thyroid-stimulating hormone;
              Thyroxine; Triiodothyronine",
  language = "en"
}

@MISC{Liu2013-qo,
  title   = "Epigenome-wide association data implicate {DNA} methylation as an
             intermediary of genetic risk in rheumatoid arthritis",
  author  = "Liu, Yun and Aryee, Martin J and Padyukov, Leonid and Daniele
             Fallin, M and Hesselberg, Espen and Runarsson, Arni and Reinius,
             Lovisa and Acevedo, Nathalie and Taub, Margaret and Ronninger,
             Marcus and Shchetynsky, Klementy and Scheynius, Annika and Kere,
             Juha and Alfredsson, Lars and Klareskog, Lars and Ekstr{\"o}m,
             Tomas J and Feinberg, Andrew P",
  journal = "Nature Biotechnology",
  volume  =  31,
  number  =  2,
  pages   = "142--147",
  year    =  2013
}

@ARTICLE{Da_Costa-Luis2019-lr,
  title    = "tqdm: A Fast, Extensible Progress Meter for Python and {CLI}",
  author   = "da Costa-Luis, Casper O",
  abstract = "Software archive",
  journal  = "JOSS",
  volume   =  4,
  number   =  37,
  pages    = "1277",
  month    =  may,
  year     =  2019
}

@MISC{Hunter2007-nq,
  title   = "Matplotlib: A {2D} Graphics Environment",
  author  = "Hunter, John D",
  journal = "Computing in Science \& Engineering",
  volume  =  9,
  number  =  3,
  pages   = "90--95",
  year    =  2007
}

@ARTICLE{Soriano-Tarraga2016-tf,
  title    = "Epigenome-wide association study identifies {TXNIP} gene
              associated with type 2 diabetes mellitus and sustained
              hyperglycemia",
  author   = "Soriano-T{\'a}rraga, Carolina and Jim{\'e}nez-Conde, Jordi and
              Giralt-Steinhauer, Eva and Mola-Caminal, Marina and
              Vivanco-Hidalgo, Rosa M and Ois, Angel and
              Rodr{\'\i}guez-Campello, Ana and Cuadrado-Godia, Elisa and
              Sayols-Baixeras, Sergi and Elosua, Roberto and Roquer, Jaume and
              {GENESTROKE Consortium}",
  abstract = "Type 2 diabetes mellitus (DM) is an established risk factor for a
              wide range of vascular diseases, including ischemic stroke (IS).
              Glycated hemoglobin A1c (HbA1c), a marker for average blood
              glucose levels over the previous 12 weeks, is used as a measure
              of glycemic control and also as a diagnostic criterion for
              diabetes (HbA1c levels $\geq$ 6.5\%). Epigenetic mechanisms, such
              as DNA methylation, may be associated with aging processes and
              with modulation of the risk of various pathologies, such as DM.
              Specifically, DNA methylation could be one of the mechanisms
              mediating the relation between DM and environmental exposures.
              Our goal was to identify new CpG methylation sites associated
              with DM. We performed a genome-wide methylation study in
              whole-blood DNA from an IS patient cohorts. Illumina
              HumanMethylation450 BeadChip array was used to measure DNA
              methylation in CpG sites. All statistical analyses were adjusted
              for sex, age, hyperlipidemia, body mass index (BMI), smoking
              habit and cell count. Findings were replicated in two independent
              cohorts, an IS cohort and a population-based cohort, using the
              same array. In the discovery phase (N = 355), we identified a CpG
              site, cg19693031 (located in the TXNIP gene) that was associated
              with DM (P = 1.17 $\times$ 10(-12)); this CpG was replicated in
              two independent cohorts (N = 167 and N = 645). Methylation of
              TXNIP was inversely and intensely associated with HbA1c levels (P
              = 7.3 $\times$ 10(-16)), specifically related to diabetic
              patients with poor control of glucose levels. We identified an
              association between the TXNIP gene and DM through epigenetic
              mechanisms, related to sustained hyperglycemia levels (HbA1c
              $\geq$ 7\%).",
  journal  = "Hum. Mol. Genet.",
  volume   =  25,
  number   =  3,
  pages    = "609--619",
  month    =  feb,
  year     =  2016,
  language = "en"
}

@UNPUBLISHED{Larison2021-ts,
  title    = "Epigenetic models predict age and aging in plains zebras and
              other equids",
  author   = "Larison, Brenda and Pinho, Gabriela M and Hagani, Amin and
              Zoller, Joseph A and Li, Caesar Z and Finno, Carrie J and
              Farrell, Colin and Kaelin, Christopher B and Barsh, Gregory S and
              Wooding, Bernard and Robeck, Todd R and Maddox, Dewey and
              Pellegrini, Matteo and Horvath, Steve",
  abstract = "Five of the seven extant wild species of the genus Equus are
              species of significant conservation concern. Effective
              conservation and management of such threatened wildlife
              populations depends on the ability to estimate demographic trends
              and population viability and therefore requires accurate
              assessment of age structure. However, reliably aging wildlife is
              challenging as many methods are highly invasive, inaccurate, or
              both. Epigenetic aging models, which estimate individual age with
              high accuracy based on genomic methylation patterns, are
              promising developments in this regard. Importantly, epigenetic
              aging models developed for one species can potentially predict
              age with high accuracy in sister taxa. Using blood and biopsy
              samples from known age plains zebras ( Equus quagga ), we
              developed epigenetic clocks (ECs) to predict chronological age,
              and epigenetic pacemaker (EPM) models to predict biological age.
              We tested the ability of our blood-based EC to predict ages of
              Grevy's zebras, Somali asses and domestic horses, from blood
              samples. Because our samples came from a population with a
              complex pedigree, we also leveraged information from a previous
              sequencing effort to measure the association between levels of
              inbreeding (F and ROH) and the age acceleration as measured by
              DNA methylation. The resulting models describe the trajectory of
              epigenetic aging in plains zebras and accurately predict the ages
              of plains zebras and other equids. We found moderate support for
              a slight acceleration of aging with increased inbreeding. \#\#\#
              Competing Interest Statement SH is a founder of the non-profit
              Epigenetic Clock Development Foundation which plans to license
              several patents from his employer UC Regents. These patents list
              SH as inventor. The other authors declare no conflicts of
              interest.",
  journal  = "bioRxiv",
  pages    = "2021.03.29.437607",
  month    =  mar,
  year     =  2021,
  language = "en"
}

@ARTICLE{Tan2014-ns,
  title    = "Epigenetic signature of birth weight discordance in adult twins",
  author   = "Tan, Qihua and Frost, Morten and Heijmans, Bastiaan T and von
              Bornemann Hjelmborg, Jacob and Tobi, Elmar W and Christensen,
              Kaare and Christiansen, Lene",
  abstract = "BACKGROUND: A low birth weight has been extensively related to
              poor adult health outcomes. Birth weight can be seen as a proxy
              for environmental conditions during prenatal development.
              Identical twin pairs discordant for birth weight provide an
              extraordinary model for investigating the association between
              birth weight and adult life health while controlling for not only
              genetics but also postnatal rearing environment. We performed an
              epigenome-wide profiling on blood samples from 150 pairs of adult
              monozygotic twins discordant for birth weight to look for
              molecular evidence of epigenetic signatures in association with
              birth weight discordance. RESULTS: Our association analysis
              revealed no CpG site with genome-wide statistical significance
              (FDR < 0.05) for either qualitative (larger or smaller) or
              quantitative discordance in birth weight. Even with selected
              samples of extremely birth weight discordant twin pairs, no
              significant site was found except for 3 CpGs that displayed
              age-dependent intra-pair differential methylation with FDRs 0.014
              (cg26856578, p = 3.42e-08), 0.0256 (cg15122603, p = 1.25e-07) and
              0.0258 (cg16636641, p = 2.05e-07). Among the three sites,
              intra-pair differential methylation increased with age for
              cg26856578 but decreased with age for cg15122603 and cg16636641.
              There was no genome-wide statistical significance for
              sex-dependent effects on intra-pair differential methylation in
              either the whole samples or the extremely discordant twins.
              CONCLUSIONS: Genome-wide DNA methylation profiling did not reveal
              epigenetic signatures of birth weight discordance although some
              sites displayed age-dependent intra-pair differential methylation
              in the extremely discordant twin pairs.",
  journal  = "BMC Genomics",
  volume   =  15,
  pages    = "1062",
  month    =  dec,
  year     =  2014,
  language = "en"
}

@ARTICLE{Pidsley2016-bg,
  title    = "Critical evaluation of the Illumina {MethylationEPIC} {BeadChip}
              microarray for whole-genome {DNA} methylation profiling",
  author   = "Pidsley, Ruth and Zotenko, Elena and Peters, Timothy J and
              Lawrence, Mitchell G and Risbridger, Gail P and Molloy, Peter and
              Van Djik, Susan and Muhlhausler, Beverly and Stirzaker, Clare and
              Clark, Susan J",
  abstract = "BACKGROUND: In recent years the Illumina HumanMethylation450
              (HM450) BeadChip has provided a user-friendly platform to profile
              DNA methylation in human samples. However, HM450 lacked coverage
              of distal regulatory elements. Illumina have now released the
              MethylationEPIC (EPIC) BeadChip, with new content specifically
              designed to target these regions. We have used HM450 and
              whole-genome bisulphite sequencing (WGBS) to perform a critical
              evaluation of the new EPIC array platform. RESULTS: EPIC covers
              over 850,000 CpG sites, including >90 \% of the CpGs from the
              HM450 and an additional 413,743 CpGs. Even though the additional
              probes improve the coverage of regulatory elements, including 58
              \% of FANTOM5 enhancers, only 7 \% distal and 27 \% proximal
              ENCODE regulatory elements are represented. Detailed comparisons
              of regulatory elements from EPIC and WGBS show that a single EPIC
              probe is not always informative for those distal regulatory
              elements showing variable methylation across the region. However,
              overall data from the EPIC array at single loci are highly
              reproducible across technical and biological replicates and
              demonstrate high correlation with HM450 and WGBS data. We show
              that the HM450 and EPIC arrays distinguish differentially
              methylated probes, but the absolute agreement depends on the
              threshold set for each platform. Finally, we provide an annotated
              list of probes whose signal could be affected by
              cross-hybridisation or underlying genetic variation. CONCLUSION:
              The EPIC array is a significant improvement over the HM450 array,
              with increased genome coverage of regulatory regions and high
              reproducibility and reliability, providing a valuable tool for
              high-throughput human methylome analyses from diverse clinical
              samples.",
  journal  = "Genome Biol.",
  volume   =  17,
  number   =  1,
  pages    = "208",
  month    =  oct,
  year     =  2016,
  keywords = "DNA methylation; EPIC; Enhancers; HM450; Microarray; Validation;
              Whole-genome bisulphite sequencing (WGBS)",
  language = "en"
}

@ARTICLE{Curtis2019-gz,
  title    = "Exposure to polybrominated biphenyl ({PBB}) associates with
              genome-wide {DNA} methylation differences in peripheral blood",
  author   = "Curtis, Sarah W and Cobb, Dawayland O and Kilaru, Varun and
              Terrell, Metrecia L and Kennedy, Elizabeth M and Marder, M
              Elizabeth and Barr, Dana Boyd and Marsit, Carmen J and Marcus,
              Michele and Conneely, Karen N and Smith, Alicia K",
  abstract = "In 1973, Michigan residents were exposed to polybrominated
              biphenyl (PBB) when it was accidentally added to farm animal
              feed. Highly exposed individuals and their children have
              experienced endocrine-related health problems, though the
              underlying mechanism behind these remains unknown. We
              investigated whether PBB exposure is associated with variation in
              DNA methylation in peripheral blood samples from 658 participants
              of the Michigan PBB registry using the MethylationEPIC BeadChip,
              as well as investigated what the potential function of the
              affected regions are and whether these epigenetic marks are known
              to associate with endocrine system pathways. After multiple test
              correction (FDR <0.05), 1890 CpG sites associated with total PBB
              levels. These CpGs were not enriched in any particular biological
              pathway, but were enriched in enhancer and insulator regions, and
              depleted in regions near the transcription start site or in CpG
              islands (p < 0.05). They were also more likely to be in ARNT and
              ESR2 transcription factor binding sites (p = 3.27e-23 and p =
              1.62e-6, respectively), and there was significant overlap between
              CpGs associated with PBB and CpGs associated with estrogen (p <
              2.2e-16). PBB-associated CpGs were also enriched for CpGs known
              to be associated with gene expression in blood (eQTMs) (p <
              0.05). These eQTMs were enriched for pathways related to immune
              function and endocrine-related autoimmune disease (FDR <0.05).
              These results indicate that exposure to PBB is associated with
              differences in epigenetic marks that suggest that it is acting
              similarly to estrogen and is associated with dysregulated immune
              system pathways.",
  journal  = "Epigenetics",
  volume   =  14,
  number   =  1,
  pages    = "52--66",
  month    =  jan,
  year     =  2019,
  keywords = "DNA methylation; Endocrine-disrupting compound; environmental
              health; epigenetics; epigenome-wide association study (EWAS);
              polybrominated biphenyl",
  language = "en"
}

@ARTICLE{Damaso2020-gd,
  title    = "Comprehensive Constitutional Genetic and Epigenetic
              Characterization of {Lynch-Like} Individuals",
  author   = "D{\'a}maso, Estela and Gonz{\'a}lez-Acosta, Maribel and
              Vargas-Parra, Gardenia and Navarro, Matilde and Balma{\~n}a,
              Judith and Ramon Y Cajal, Teresa and Tuset, Noem{\'\i} and
              Thompson, Bryony A and Mar{\'\i}n, F{\'a}tima and Fern{\'a}ndez,
              Anna and G{\'o}mez, Carolina and Velasco, {\`A}ngela and Solanes,
              Ares and Iglesias, S{\'\i}lvia and Urgel, Gisela and L{\'o}pez,
              Consol and Del Valle, Jes{\'u}s and Campos, Olga and Santacana,
              Maria and Matias-Guiu, Xavier and L{\'a}zaro, Conxi and Valle,
              Laura and Brunet, Joan and Pineda, Marta and Capell{\'a}, Gabriel",
  abstract = "The causal mechanism for cancer predisposition in Lynch-like
              syndrome (LLS) remains unknown. Our aim was to elucidate the
              constitutional basis of mismatch repair (MMR) deficiency in LLS
              patients throughout a comprehensive (epi)genetic analysis. One
              hundred and fifteen LLS patients harboring MMR-deficient tumors
              and no germline MMR mutations were included. Mutational analysis
              of 26 colorectal cancer (CRC)-associated genes was performed.
              Pathogenicity of MMR variants was assessed by splicing and
              multifactorial likelihood analyses. Genome-wide methylome
              analysis was performed by the Infinium Human Methylation 450K
              Bead Chip. The multigene panel analysis revealed the presence of
              two MMR gene truncating mutations not previously found. Of a
              total of 15 additional MMR variants identified, five -present in
              6 unrelated individuals- were reclassified as pathogenic. In
              addition, 13 predicted deleterious variants in other
              CRC-predisposing genes were found in 12 probands. Methylome
              analysis detected one constitutional MLH1 epimutation, but no
              additional differentially methylated regions were identified in
              LLS compared to LS patients or cancer-free individuals. In
              conclusion, the use of an ad-hoc designed gene panel combined
              with pathogenicity assessment of variants allowed the
              identification of deleterious MMR mutations as well as new LLS
              candidate causal genes. Constitutional epimutations in
              non-LS-associated genes are not responsible for LLS.",
  journal  = "Cancers",
  volume   =  12,
  number   =  7,
  month    =  jul,
  year     =  2020,
  keywords = "Lynch syndrome; Lynch-like syndrome; cancer genes panel;
              epimutation; methylation; mismatch repair; next generation
              sequencing; variant of unknown significance",
  language = "en"
}

@ARTICLE{Braun2019-gp,
  title    = "Genome-wide {DNA} methylation comparison between live human brain
              and peripheral tissues within individuals",
  author   = "Braun, Patricia R and Han, Shizhong and Hing, Benjamin and
              Nagahama, Yasunori and Gaul, Lindsey N and Heinzman, Jonathan T
              and Grossbach, Andrew J and Close, Liesl and Dlouhy, Brian J and
              Howard, 3rd, Matthew A and Kawasaki, Hiroto and Potash, James B
              and Shinozaki, Gen",
  abstract = "Differential DNA methylation in the brain is associated with many
              psychiatric diseases, but access to brain tissues is essentially
              limited to postmortem samples. The use of surrogate tissues has
              become common in identifying methylation changes associated with
              psychiatric disease. In this study, we determined the extent to
              which peripheral tissues can be used as surrogates for DNA
              methylation in the brain. Blood, saliva, buccal, and live brain
              tissue samples from 27 patients with medically intractable
              epilepsy undergoing brain resection were collected (age range
              5-61 years). Genome-wide methylation was assessed with the
              Infinium HumanMethylation450 (n = 12) and HumanMethylationEPIC
              BeadChip arrays (n = 21). For the EPIC methylation data averaged
              for each CpG across subjects, the saliva-brain correlation (r =
              0.90) was higher than that for blood-brain (r = 0.86) and
              buccal-brain (r = 0.85) comparisons. However, within individual
              CpGs, blood had the highest proportion of CpGs correlated to
              brain at nominally significant levels (20.8\%), as compared to
              buccal tissue (17.4\%) and saliva (15.1\%). For each CpG and each
              gene, levels of brain-peripheral tissue correlation varied
              widely. This indicates that to determine the most useful
              surrogate tissue for representing brain DNA methylation, the
              patterns specific to the genomic region of interest must be
              considered. To assist in that objective, we have developed a
              website, IMAGE-CpG, that allows researchers to interrogate DNA
              methylation levels and degree of cross-tissue correlation in
              user-defined locations across the genome.",
  journal  = "Transl. Psychiatry",
  volume   =  9,
  number   =  1,
  pages    = "47",
  month    =  jan,
  year     =  2019,
  language = "en"
}

@ARTICLE{Snir2019-ii,
  title    = "Human epigenetic ageing is logarithmic with time across the
              entire lifespan",
  author   = "Snir, Sagi and Farrell, Colin and Pellegrini, Matteo",
  abstract = "Epigenetic changes during ageing have been characterized by
              multiple epigenetic clocks that allow the prediction of
              chronological age based on methylation status. Despite their
              accuracy and utility, epigenetic age biomarkers leave many
              questions about epigenetic ageing unanswered. Specifically, they
              do not permit the unbiased characterization of non-linear
              epigenetic ageing trends across entire life spans, a critical
              question underlying this field of research. Here we provide an
              integrated framework to address this question. Our model,
              inspired from evolutionary models, is able to account for
              acceleration/deceleration in epigenetic changes by fitting an
              individual's model age, the epigenetic age, which is related to
              chronological age in a non-linear fashion. Application of this
              model to DNA methylation data measured across broad age ranges,
              from before birth to old age, and from two tissue types, suggests
              a universal logarithmic trend characterizes epigenetic ageing
              across entire lifespans.",
  journal  = "Epigenetics",
  volume   =  14,
  number   =  9,
  pages    = "912--926",
  month    =  sep,
  year     =  2019,
  keywords = "Aging; DNA methylation",
  language = "en"
}

@ARTICLE{Johansson2013-of,
  title    = "Continuous Aging of the Human {DNA} Methylome Throughout the
              Human Lifespan",
  author   = "Johansson, Asa and Enroth, Stefan and Gyllensten, Ulf",
  abstract = "DNA methylation plays an important role in development of disease
              and the process of aging. In this study we examine DNA
              methylation at 476,366 sites throughout the genome of white blood
              cells from a population cohort (N = 421) ranging in age from 14
              to 94 years old. Age affects DNA methylation at almost one third
              (29\%) of the sites (Bonferroni adjusted P-value <0.05), of which
              60.5\% becomes hypomethylated and 39.5\% hypermethylated with
              increasing age. DNA methylation sites that are located within CpG
              islands (CGIs) more often become hypermethylated compared to
              sites outside an island. CpG sites in promoters are more
              unaffected by age, whereas sites in enhancers more often becomes
              hypo- or hypermethylated. Hypermethylated sites are
              overrepresented among genes that are involved in DNA binding,
              transcription regulation, processes of anatomical structure and
              developmental process and cortex neuron differentiation (P-value
              down to P = 9.14*10(-67)). By contrast, hypomethylated sites are
              not strongly overrepresented among any biological function or
              process. Our results indicate that the 23\% of the variation in
              DNA methylation is attributed chronological age, and that
              hypermethylation is more site-specific than hypomethylation. It
              appears that the change in DNA methylation partly overlap with
              regions that change histone modifications with age, indicating an
              interaction between the two major epigenetic mechanisms.
              Epigenetic modifications and change in gene expression over time
              most likely reflects the natural process of aging and variation
              between individuals might contribute to the development of
              age-related phenotypes and diseases such as type II diabetes,
              autoimmune and cardiovascular disease.",
  journal  = "PLoS One",
  volume   =  8,
  number   =  6,
  pages    = "e67378",
  month    =  jun,
  year     =  2013,
  language = "en"
}

@ARTICLE{Butcher2017-nr,
  title    = "{CHARGE} and Kabuki Syndromes: {Gene-Specific} {DNA} Methylation
              Signatures Identify Epigenetic Mechanisms Linking These
              Clinically Overlapping Conditions",
  author   = "Butcher, Darci T and Cytrynbaum, Cheryl and Turinsky, Andrei L
              and Siu, Michelle T and Inbar-Feigenberg, Michal and
              Mendoza-Londono, Roberto and Chitayat, David and Walker, Susan
              and Machado, Jerry and Caluseriu, Oana and Dupuis, Lucie and
              Grafodatskaya, Daria and Reardon, William and Gilbert-Dussardier,
              Brigitte and Verloes, Alain and Bilan, Frederic and Milunsky,
              Jeff M and Basran, Raveen and Papsin, Blake and Stockley, Tracy L
              and Scherer, Stephen W and Choufani, Sanaa and Brudno, Michael
              and Weksberg, Rosanna",
  abstract = "Epigenetic dysregulation has emerged as a recurring mechanism in
              the etiology of neurodevelopmental disorders. Two such disorders,
              CHARGE and Kabuki syndromes, result from loss of function
              mutations in chromodomain helicase DNA-binding protein 7
              (CHD7LOF) and lysine (K) methyltransferase 2D (KMT2DLOF),
              respectively. Although these two syndromes are clinically
              distinct, there is significant phenotypic overlap. We therefore
              expected that epigenetically driven developmental pathways
              regulated by CHD7 and KMT2D would overlap and that DNA
              methylation (DNAm) alterations downstream of the mutations in
              these genes would identify common target genes, elucidating a
              mechanistic link between these two conditions, as well as
              specific target genes for each disorder. Genome-wide DNAm
              profiles in individuals with CHARGE and Kabuki syndromes with
              CHD7LOF or KMT2DLOF identified distinct sets of DNAm differences
              in each of the disorders, which were used to generate two unique,
              highly specific and sensitive DNAm signatures. These DNAm
              signatures were able to differentiate pathogenic mutations in
              these two genes from controls and from each other. Analysis of
              the DNAm targets in each gene-specific signature identified both
              common gene targets, including homeobox A5 (HOXA5), which could
              account for some of the clinical overlap in CHARGE and Kabuki
              syndromes, as well as distinct gene targets. Our findings
              demonstrate how characterization of the epigenome can contribute
              to our understanding of disease pathophysiology for epigenetic
              disorders, paving the way for explorations of novel therapeutics.",
  journal  = "Am. J. Hum. Genet.",
  volume   =  100,
  number   =  5,
  pages    = "773--788",
  month    =  may,
  year     =  2017,
  keywords = "CHARGE syndrome; DNA methylation; Epigenetics; Kabuki syndrome;
              chromodomain helicase DNA-binding protein 7 (CHD7); lysine (K)
              methyltransferase 2D (KMT2D)",
  language = "en"
}

@MISC{Perna2016-pi,
  title   = "Epigenetic age acceleration predicts cancer, cardiovascular, and
             all-cause mortality in a German case cohort",
  author  = "Perna, Laura and Zhang, Yan and Mons, Ute and Holleczek, Bernd and
             Saum, Kai-Uwe and Brenner, Hermann",
  journal = "Clinical Epigenetics",
  volume  =  8,
  number  =  1,
  year    =  2016
}

@ARTICLE{Varoquaux2009-al,
  title   = "Joblib: running python function as pipeline jobs",
  author  = "Varoquaux, Ga{\"e}l and Grisel, O",
  journal = "packages. python. org/joblib",
  year    =  2009
}

@ARTICLE{Marioni2015-sn,
  title    = "{DNA} methylation age of blood predicts all-cause mortality in
              later life",
  author   = "Marioni, Riccardo E and Shah, Sonia and McRae, Allan F and Chen,
              Brian H and Colicino, Elena and Harris, Sarah E and Gibson, Jude
              and Henders, Anjali K and Redmond, Paul and Cox, Simon R and
              Pattie, Alison and Corley, Janie and Murphy, Lee and Martin,
              Nicholas G and Montgomery, Grant W and Feinberg, Andrew P and
              Fallin, M Daniele and Multhaup, Michael L and Jaffe, Andrew E and
              Joehanes, Roby and Schwartz, Joel and Just, Allan C and Lunetta,
              Kathryn L and Murabito, Joanne M and Starr, John M and Horvath,
              Steve and Baccarelli, Andrea A and Levy, Daniel and Visscher,
              Peter M and Wray, Naomi R and Deary, Ian J",
  abstract = "BACKGROUND: DNA methylation levels change with age. Recent
              studies have identified biomarkers of chronological age based on
              DNA methylation levels. It is not yet known whether DNA
              methylation age captures aspects of biological age. RESULTS: Here
              we test whether differences between people's chronological ages
              and estimated ages, DNA methylation age, predict all-cause
              mortality in later life. The difference between DNA methylation
              age and chronological age ($\Delta$age) was calculated in four
              longitudinal cohorts of older people. Meta-analysis of
              proportional hazards models from the four cohorts was used to
              determine the association between $\Delta$age and mortality. A
              5-year higher $\Delta$age is associated with a 21\% higher
              mortality risk, adjusting for age and sex. After further
              adjustments for childhood IQ, education, social class,
              hypertension, diabetes, cardiovascular disease, and APOE e4
              status, there is a 16\% increased mortality risk for those with a
              5-year higher $\Delta$age. A pedigree-based heritability analysis
              of $\Delta$age was conducted in a separate cohort. The
              heritability of $\Delta$age was 0.43. CONCLUSIONS: DNA
              methylation-derived measures of accelerated aging are heritable
              traits that predict mortality independently of health status,
              lifestyle factors, and known genetic factors.",
  journal  = "Genome Biol.",
  volume   =  16,
  pages    = "25",
  month    =  jan,
  year     =  2015,
  language = "en"
}

@ARTICLE{Hannum2013-um,
  title    = "Genome-wide methylation profiles reveal quantitative views of
              human aging rates",
  author   = "Hannum, Gregory and Guinney, Justin and Zhao, Ling and Zhang, Li
              and Hughes, Guy and Sadda, Srinivas and Klotzle, Brandy and
              Bibikova, Marina and Fan, Jian-Bing and Gao, Yuan and Deconde,
              Rob and Chen, Menzies and Rajapakse, Indika and Friend, Stephen
              and Ideker, Trey and Zhang, Kang",
  abstract = "The ability to measure human aging from molecular profiles has
              practical implications in many fields, including disease
              prevention and treatment, forensics, and extension of life.
              Although chronological age has been linked to changes in DNA
              methylation, the methylome has not yet been used to measure and
              compare human aging rates. Here, we build a quantitative model of
              aging using measurements at more than 450,000 CpG markers from
              the whole blood of 656 human individuals, aged 19 to 101. This
              model measures the rate at which an individual's methylome ages,
              which we show is impacted by gender and genetic variants. We also
              show that differences in aging rates help explain epigenetic
              drift and are reflected in the transcriptome. Moreover, we show
              how our aging model is upheld in other human tissues and reveals
              an advanced aging rate in tumor tissue. Our model highlights
              specific components of the aging process and provides a
              quantitative readout for studying the role of methylation in
              age-related disease.",
  journal  = "Mol. Cell",
  volume   =  49,
  number   =  2,
  pages    = "359--367",
  month    =  jan,
  year     =  2013,
  language = "en"
}

@ARTICLE{Huang2019-hf,
  title    = "Epigenetic Age Acceleration in Adolescence Associates With {BMI},
              Inflammation, and Risk Score for Middle Age Cardiovascular
              Disease",
  author   = "Huang, Rae-Chi and Lillycrop, Karen A and Beilin, Lawrence J and
              Godfrey, Keith M and Anderson, Denise and Mori, Trevor A and
              Rauschert, Sebastian and Craig, Jeffrey M and Oddy, Wendy H and
              Ayonrinde, Oyekoya T and Pennell, Craig E and Holbrook, Joanna D
              and Melton, Phillip E",
  abstract = "CONTEXT: ``Accelerated aging,'' assessed by adult DNA
              methylation, predicts cardiovascular disease (CVD). Adolescent
              accelerated aging might predict CVD earlier. We investigated
              whether epigenetic age acceleration (assessed age, 17 years) was
              associated with adiposity/CVD risk measured (ages 17, 20, and 22
              years) and projected CVD by middle age. DESIGN: DNA methylation
              measured in peripheral blood provided two estimates of epigenetic
              age acceleration: intrinsic (IEAA; preserved across cell types)
              and extrinsic (EEAA; dependent on cell admixture and methylation
              levels within each cell type). Adiposity was assessed by
              anthropometry, ultrasound, and dual-energy x-ray absorptiometry
              (ages 17, 20, and 22 years). CVD risk factors [lipids,
              homeostatic model assessment of insulin resistance (HOMA-IR),
              blood pressure, inflammatory markers] were assessed at age 17
              years. CVD development by age 47 years was calculated by
              Framingham algorithms. Results are presented as regression
              coefficients per 5-year epigenetic age acceleration (IEAA/EEAA)
              for adiposity, CVD risk factors, and CVD development. RESULTS: In
              995 participants (49.6\% female; age, 17.3 $\pm$ 0.6 years), EEAA
              (per 5 years) was associated with increased body mass index (BMI)
              of 2.4\% (95\% CI, 1.2\% to 3.6\%) and 2.4\% (0.8\% to 3.9\%) at
              17 and 22 years, respectively. EEAA was associated with increases
              of 23\% (3\% to 33\%) in high-sensitivity C-reactive protein,
              10\% (4\% to 17\%) in interferon-$\gamma$-inducible protein of 10
              kDa, and 4\% (2\% to 6\%) in soluble TNF receptor 2, adjusted for
              BMI and HOMA-IR. EEAA (per 5 years) results in a 4\% increase in
              hard endpoints of CVD by 47 years of age and a 3\% increase,
              after adjustment for conventional risk factors. CONCLUSIONS:
              Accelerated epigenetic age in adolescence was associated with
              inflammation, BMI measured 5 years later, and probability of
              middle age CVD. Irrespective of whether this is cause or effect,
              assessing epigenetic age might refine disease prediction.",
  journal  = "J. Clin. Endocrinol. Metab.",
  volume   =  104,
  number   =  7,
  pages    = "3012--3024",
  month    =  jul,
  year     =  2019,
  language = "en"
}

@ARTICLE{Houseman2012-rr,
  title    = "{DNA} methylation arrays as surrogate measures of cell mixture
              distribution",
  author   = "Houseman, Eugene Andres and Accomando, William P and Koestler,
              Devin C and Christensen, Brock C and Marsit, Carmen J and Nelson,
              Heather H and Wiencke, John K and Kelsey, Karl T",
  abstract = "BACKGROUND: There has been a long-standing need in biomedical
              research for a method that quantifies the normally mixed
              composition of leukocytes beyond what is possible by simple
              histological or flow cytometric assessments. The latter is
              restricted by the labile nature of protein epitopes, requirements
              for cell processing, and timely cell analysis. In a diverse array
              of diseases and following numerous immune-toxic exposures,
              leukocyte composition will critically inform the underlying
              immuno-biology to most chronic medical conditions. Emerging
              research demonstrates that DNA methylation is responsible for
              cellular differentiation, and when measured in whole peripheral
              blood, serves to distinguish cancer cases from controls. RESULTS:
              Here we present a method, similar to regression calibration, for
              inferring changes in the distribution of white blood cells
              between different subpopulations (e.g. cases and controls) using
              DNA methylation signatures, in combination with a previously
              obtained external validation set consisting of signatures from
              purified leukocyte samples. We validate the fundamental idea in a
              cell mixture reconstruction experiment, then demonstrate our
              method on DNA methylation data sets from several studies,
              including data from a Head and Neck Squamous Cell Carcinoma
              (HNSCC) study and an ovarian cancer study. Our method produces
              results consistent with prior biological findings, thereby
              validating the approach. CONCLUSIONS: Our method, in combination
              with an appropriate external validation set, promises new
              opportunities for large-scale immunological studies of both
              disease states and noxious exposures.",
  journal  = "BMC Bioinformatics",
  volume   =  13,
  pages    = "86",
  month    =  may,
  year     =  2012,
  language = "en"
}

@ARTICLE{Horvath2014-nx,
  title    = "Obesity accelerates epigenetic aging of human liver",
  author   = "Horvath, Steve and Erhart, Wiebke and Brosch, Mario and
              Ammerpohl, Ole and von Sch{\"o}nfels, Witigo and Ahrens, Markus
              and Heits, Nils and Bell, Jordana T and Tsai, Pei-Chien and
              Spector, Tim D and Deloukas, Panos and Siebert, Reiner and Sipos,
              Bence and Becker, Thomas and R{\"o}cken, Christoph and
              Schafmayer, Clemens and Hampe, Jochen",
  abstract = "Because of the dearth of biomarkers of aging, it has been
              difficult to test the hypothesis that obesity increases tissue
              age. Here we use a novel epigenetic biomarker of aging (referred
              to as an ``epigenetic clock'') to study the relationship between
              high body mass index (BMI) and the DNA methylation ages of human
              blood, liver, muscle, and adipose tissue. A significant
              correlation between BMI and epigenetic age acceleration could
              only be observed for liver (r = 0.42, P = 6.8 $\times$ 10(-4) in
              dataset 1 and r = 0.42, P = 1.2 $\times$ 10(-4) in dataset 2). On
              average, epigenetic age increased by 3.3 y for each 10 BMI units.
              The detected age acceleration in liver is not associated with the
              Nonalcoholic Fatty Liver Disease Activity Score or any of its
              component traits after adjustment for BMI. The 279 genes that are
              underexpressed in older liver samples are highly enriched (1.2
              $\times$ 10(-9)) with nuclear mitochondrial genes that play a
              role in oxidative phosphorylation and electron transport. The
              epigenetic age acceleration, which is not reversible in the short
              term after rapid weight loss induced by bariatric surgery, may
              play a role in liver-related comorbidities of obesity, such as
              insulin resistance and liver cancer.",
  journal  = "Proc. Natl. Acad. Sci. U. S. A.",
  volume   =  111,
  number   =  43,
  pages    = "15538--15543",
  month    =  oct,
  year     =  2014,
  keywords = "DNA methylation; aging; biological age; epigenetics; obesity",
  language = "en"
}

@ARTICLE{Pedregosa2011-fi,
  title   = "Scikit-learn: Machine Learning in {P}ython",
  author  = "Pedregosa, F and Varoquaux, G and Gramfort, A and Michel, V and
             Thirion, B and Grisel, O and Blondel, M and Prettenhofer, P and
             Weiss, R and Dubourg, V and Vanderplas, J and Passos, A and
             Cournapeau, D and Brucher, M and Perrot, M and Duchesnay, E",
  journal = "J. Mach. Learn. Res.",
  volume  =  12,
  pages   = "2825--2830",
  year    =  2011
}

@ARTICLE{Safe1984-sz,
  title    = "Polychlorinated biphenyls ({PCBs}) and polybrominated biphenyls
              ({PBBs)}: biochemistry, toxicology, and mechanism of action",
  author   = "Safe, S",
  abstract = "Polychlorinated and polybrominated biphenyls are industrial
              chemical mixtures which have been implicated in numerous human
              poisonings in Taiwan and Japan (PCBs) and Michigan (PBBs).
              Moreover, these polyhalogenated biphenyls have been widely
              detected in the environment including the air, water, fish,
              wildlife, human adipose tissue, and blood and breast milk. A
              major problem associated with the analysis and toxicology of this
              group of chemicals is their chemical complexity (e.g., there are
              209 possible PCB isomers and congeners) and the remarkable
              effects of structure on activity. This article will discuss the
              effects of structure on the biologic and toxic effects of
              individual PCB and PBB congeners as well as reconstituted
              mixtures. The results clearly show that like ``dioxin'' (or
              2,3,7,8-TCDD), the PCBs and PBBs elicit their effects through a
              cytosolic receptor protein which preferentially binds with the
              toxins which are approximate isostereomers of 2,3,7,8-TCDD. The
              evidence for this mechanism of action will be discussed in
              detail.",
  journal  = "Crit. Rev. Toxicol.",
  volume   =  13,
  number   =  4,
  pages    = "319--395",
  year     =  1984,
  language = "en"
}

@ARTICLE{Virtanen2020-wt,
  title    = "{SciPy} 1.0: fundamental algorithms for scientific computing in
              Python",
  author   = "Virtanen, Pauli and Gommers, Ralf and Oliphant, Travis E and
              Haberland, Matt and Reddy, Tyler and Cournapeau, David and
              Burovski, Evgeni and Peterson, Pearu and Weckesser, Warren and
              Bright, Jonathan and van der Walt, St{\'e}fan J and Brett,
              Matthew and Wilson, Joshua and Millman, K Jarrod and Mayorov,
              Nikolay and Nelson, Andrew R J and Jones, Eric and Kern, Robert
              and Larson, Eric and Carey, C J and Polat, {\.I}lhan and Feng, Yu
              and Moore, Eric W and VanderPlas, Jake and Laxalde, Denis and
              Perktold, Josef and Cimrman, Robert and Henriksen, Ian and
              Quintero, E A and Harris, Charles R and Archibald, Anne M and
              Ribeiro, Ant{\^o}nio H and Pedregosa, Fabian and van Mulbregt,
              Paul and Vijaykumar, Aditya and Bardelli, Alessandro Pietro and
              Rothberg, Alex and Hilboll, Andreas and Kloeckner, Andreas and
              Scopatz, Anthony and Lee, Antony and Rokem, Ariel and Woods, C
              Nathan and Fulton, Chad and Masson, Charles and
              H{\"a}ggstr{\"o}m, Christian and Fitzgerald, Clark and Nicholson,
              David A and Hagen, David R and Pasechnik, Dmitrii V and Olivetti,
              Emanuele and Martin, Eric and Wieser, Eric and Silva, Fabrice and
              Lenders, Felix and Wilhelm, Florian and Young, G and Price, Gavin
              A and Ingold, Gert-Ludwig and Allen, Gregory E and Lee, Gregory R
              and Audren, Herv{\'e} and Probst, Irvin and Dietrich, J{\"o}rg P
              and Silterra, Jacob and Webber, James T and Slavi{\v c}, Janko
              and Nothman, Joel and Buchner, Johannes and Kulick, Johannes and
              Sch{\"o}nberger, Johannes L and de Miranda Cardoso, Jos{\'e}
              Vin{\'\i}cius and Reimer, Joscha and Harrington, Joseph and
              Rodr{\'\i}guez, Juan Luis Cano and Nunez-Iglesias, Juan and
              Kuczynski, Justin and Tritz, Kevin and Thoma, Martin and
              Newville, Matthew and K{\"u}mmerer, Matthias and Bolingbroke,
              Maximilian and Tartre, Michael and Pak, Mikhail and Smith,
              Nathaniel J and Nowaczyk, Nikolai and Shebanov, Nikolay and
              Pavlyk, Oleksandr and Brodtkorb, Per A and Lee, Perry and
              McGibbon, Robert T and Feldbauer, Roman and Lewis, Sam and
              Tygier, Sam and Sievert, Scott and Vigna, Sebastiano and
              Peterson, Stefan and More, Surhud and Pudlik, Tadeusz and Oshima,
              Takuya and Pingel, Thomas J and Robitaille, Thomas P and Spura,
              Thomas and Jones, Thouis R and Cera, Tim and Leslie, Tim and
              Zito, Tiziano and Krauss, Tom and Upadhyay, Utkarsh and
              Halchenko, Yaroslav O and V{\'a}zquez-Baeza, Yoshiki and {SciPy
              1.0 Contributors}",
  abstract = "SciPy is an open-source scientific computing library for the
              Python programming language. Since its initial release in 2001,
              SciPy has become a de facto standard for leveraging scientific
              algorithms in Python, with over 600 unique code contributors,
              thousands of dependent packages, over 100,000 dependent
              repositories and millions of downloads per year. In this work, we
              provide an overview of the capabilities and development practices
              of SciPy 1.0 and highlight some recent technical developments.",
  journal  = "Nat. Methods",
  month    =  feb,
  year     =  2020
}

@ARTICLE{Marabita2018-yi,
  title    = "Author Correction: Smoking induces {DNA} methylation changes in
              Multiple Sclerosis patients with exposure-response relationship",
  author   = "Marabita, Francesco and Almgren, Malin and Sj{\"o}holm, Louise K
              and Kular, Lara and Liu, Yun and James, Tojo and Kiss, Nimrod B
              and Feinberg, Andrew P and Olsson, Tomas and Kockum, Ingrid and
              Alfredsson, Lars and Ekstr{\"o}m, Tomas J and Jagodic, Maja",
  abstract = "A correction to this article has been published and is linked
              from the HTML and PDF versions of this paper. The error has not
              been fixed in the paper.",
  journal  = "Sci. Rep.",
  volume   =  8,
  number   =  1,
  pages    = "4340",
  month    =  mar,
  year     =  2018,
  language = "en"
}

@MISC{Voisin2015-ch,
  title   = "Many obesity-associated {SNPs} strongly associate with {DNA}
             methylation changes at proximal promoters and enhancers",
  author  = "Voisin, Sarah and Alm{\'e}n, Markus S{\"a}llman and Zheleznyakova,
             Galina Y and Lundberg, Lina and Zarei, Sanaz and Castillo, Sandra
             and Eriksson, Fia Ence and Nilsson, Emil K and Bl{\"u}her,
             Matthias and B{\"o}ttcher, Yvonne and Kovacs, Peter and Klovins,
             Janis and Rask-Andersen, Mathias and Schi{\"o}th, Helgi B",
  journal = "Genome Medicine",
  volume  =  7,
  number  =  1,
  year    =  2015
}

@MISC{Dabin_undated-pr,
  title  = "Altered {DNA} methylation profiles in blood from patients with
            sporadic {Creutzfeldt-Jakob} disease",
  author = "Dabin, Luke and Guntoro, Fernando and Campbell, Tracy and
            B{\'e}licard, Tony and Smith, Adam R and Smith, Rebecca G and
            Raybould, Rachel and Schott, Jonathan M and Lunnon, Katie and
            Sarkies, Peter and Collinge, John and Mead, Simon and Vir{\'e},
            Emmanuelle"
}

@ARTICLE{Dugue2018-ad,
  title    = "{DNA} methylation-based biological aging and cancer risk and
              survival: Pooled analysis of seven prospective studies",
  author   = "Dugu{\'e}, Pierre-Antoine and Bassett, Julie K and Joo, Jihoon E
              and Jung, Chol-Hee and Ming Wong, Ee and Moreno-Betancur,
              Margarita and Schmidt, Daniel and Makalic, Enes and Li, Shuai and
              Severi, Gianluca and Hodge, Allison M and Buchanan, Daniel D and
              English, Dallas R and Hopper, John L and Southey, Melissa C and
              Giles, Graham G and Milne, Roger L",
  abstract = "The association between aging and cancer is complex. Recent
              studies have developed measures of biological aging based on DNA
              methylation and called them ``age acceleration.'' We aimed to
              assess the associations of age acceleration with risk of and
              survival from seven common cancers. Seven case-control studies of
              DNA methylation and colorectal, gastric, kidney, lung, prostate
              and urothelial cancer and B-cell lymphoma nested in the Melbourne
              Collaborative Cohort Study were conducted. Cancer cases, vital
              status and cause of death were ascertained through linkage with
              cancer and death registries. Conditional logistic regression and
              Cox models were used to estimate odds ratios (OR) and hazard
              ratios (HR) and 95\% confidence intervals (CI) for associations
              of five age acceleration measures derived from the Human
              Methylation 450 K Beadchip assay with cancer risk (N = 3,216
              cases) and survival (N = 1,726 deaths), respectively. Epigenetic
              aging was associated with increased cancer risk, ranging from 4\%
              to 9\% per five-year age acceleration for the 5 measures
              considered. Heterogeneity by study was observed, with stronger
              associations for risk of kidney cancer and B-cell lymphoma. An
              associated increased risk of death following cancer diagnosis
              ranged from 2\% to 6\% per five-year age acceleration, with no
              evidence of heterogeneity by cancer site. Cancer risk and
              mortality were increased by 15-30\% for the fourth versus first
              quartile of age acceleration. DNA methylation-based measures of
              biological aging are associated with increased cancer risk and
              shorter cancer survival, independently of major health risk
              factors.",
  journal  = "Int. J. Cancer",
  volume   =  142,
  number   =  8,
  pages    = "1611--1619",
  month    =  apr,
  year     =  2018,
  keywords = "DNA methylation; age acceleration; aging; biological age; blood;
              epigenetic aging; epigenetic clock; lymphoma; prospective study;
              survival",
  language = "en"
}

@ARTICLE{Zannas2019-bc,
  title     = "Epigenetic upregulation of {FKBP5} by aging and stress
               contributes to {NF-$\kappa$B--driven} inflammation and
               cardiovascular risk",
  author    = "Zannas, Anthony S and Jia, Meiwen and Hafner, Kathrin and
               Baumert, Jens and Wiechmann, Tobias and Pape, Julius C and
               Arloth, Janine and K{\"o}del, Maik and Martinelli, Silvia and
               Roitman, Maria and R{\"o}h, Simone and Haehle, Andreas and
               Emeny, Rebecca T and Iurato, Stella and Carrillo-Roa, Tania and
               Lahti, Jari and R{\"a}ikk{\"o}nen, Katri and Eriksson, Johan G
               and Drake, Amanda J and Waldenberger, Melanie and Wahl, Simone
               and Kunze, Sonja and Lucae, Susanne and Bradley, Bekh and
               Gieger, Christian and Hausch, Felix and Smith, Alicia K and
               Ressler, Kerry J and M{\"u}ller-Myhsok, Bertram and Ladwig,
               Karl-Heinz and Rein, Theo and Gassen, Nils C and Binder,
               Elisabeth B",
  abstract  = "Aging and psychosocial stress are associated with increased
               inflammation and disease risk, but the underlying molecular
               mechanisms are unclear. Because both aging and stress are also
               associated with lasting epigenetic changes, a plausible
               hypothesis is that stress along the lifespan could confer
               disease risk through epigenetic effects on molecules involved in
               inflammatory processes. Here, by combining large-scale analyses
               in human cohorts with experiments in cells, we report that
               FKBP5, a protein implicated in stress physiology, contributes to
               these relations. Across independent human cohorts (total n >
               3,000), aging synergized with stress-related phenotypes,
               measured with childhood trauma and major depression
               questionnaires, to epigenetically up-regulate FKBP5 expression.
               These age/stress-related epigenetic effects were recapitulated
               in a cellular model of replicative senescence, whereby we
               exposed replicating human fibroblasts to stress (glucocorticoid)
               hormones. Unbiased genome-wide analyses in human blood linked
               higher FKBP5 mRNA with a proinflammatory profile and altered
               NF-$\kappa$B--related gene networks. Accordingly, experiments in
               immune cells showed that higher FKBP5 promotes inflammation by
               strengthening the interactions of NF-$\kappa$B regulatory
               kinases, whereas opposing FKBP5 either by genetic deletion
               (CRISPR/Cas9-mediated) or selective pharmacological inhibition
               prevented the effects on NF-$\kappa$B. Further, the
               age/stress-related epigenetic signature enhanced FKBP5 response
               to NF-$\kappa$B through a positive feedback loop and was present
               in individuals with a history of acute myocardial infarction, a
               disease state linked to peripheral inflammation. These findings
               suggest that aging/stress-driven FKBP5--NF-$\kappa$B signaling
               mediates inflammation, potentially contributing to
               cardiovascular risk, and may thus point to novel biomarker and
               treatment possibilities.",
  journal   = "Proc. Natl. Acad. Sci. U. S. A.",
  publisher = "National Academy of Sciences",
  volume    =  116,
  number    =  23,
  pages     = "11370--11379",
  month     =  jun,
  year      =  2019,
  language  = "en"
}

@BOOK{McKinney2012-ta,
  title     = "Python for Data Analysis: Data Wrangling with Pandas, {NumPy},
               and {IPython}",
  author    = "McKinney, Wes",
  abstract  = "Python for Data Analysis is concerned with the nuts and bolts of
               manipulating, processing, cleaning, and crunching data in
               Python. It is also a practical, modern introduction to
               scientific computing in Python, tailored for data-intensive
               applications. This is a book about the parts of the Python
               language and libraries you'll need to effectively solve a broad
               set of data analysis problems. This book is not an exposition on
               analytical methods using Python as the implementation
               language.Written by Wes McKinney, the main author of the pandas
               library, this hands-on book is packed with practical cases
               studies. It's ideal for analysts new to Python and for Python
               programmers new to scientific computing.Use the IPython
               interactive shell as your primary development environmentLearn
               basic and advanced NumPy (Numerical Python) featuresGet started
               with data analysis tools in the pandas libraryUse
               high-performance tools to load, clean, transform, merge, and
               reshape dataCreate scatter plots and static or interactive
               visualizations with matplotlibApply the pandas groupby facility
               to slice, dice, and summarize datasetsMeasure data by points in
               time, whether it's specific instances, fixed periods, or
               intervalsLearn how to solve problems in web analytics, social
               sciences, finance, and economics, through detailed examples",
  publisher = "``O'Reilly Media, Inc.''",
  month     =  oct,
  year      =  2012,
  language  = "en"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Aryee2014-ky,
  title    = "Minfi: a flexible and comprehensive Bioconductor package for the
              analysis of Infinium {DNA} methylation microarrays",
  author   = "Aryee, Martin J and Jaffe, Andrew E and Corrada-Bravo, Hector and
              Ladd-Acosta, Christine and Feinberg, Andrew P and Hansen, Kasper
              D and Irizarry, Rafael A",
  abstract = "MOTIVATION: The recently released Infinium HumanMethylation450
              array (the '450k' array) provides a high-throughput assay to
              quantify DNA methylation (DNAm) at 450 000 loci across a range
              of genomic features. Although less comprehensive than
              high-throughput sequencing-based techniques, this product is more
              cost-effective and promises to be the most widely used DNAm
              high-throughput measurement technology over the next several
              years. RESULTS: Here we describe a suite of computational tools
              that incorporate state-of-the-art statistical techniques for the
              analysis of DNAm data. The software is structured to easily adapt
              to future versions of the technology. We include methods for
              preprocessing, quality assessment and detection of differentially
              methylated regions from the kilobase to the megabase scale. We
              show how our software provides a powerful and flexible
              development platform for future methods. We also illustrate how
              our methods empower the technology to make discoveries previously
              thought to be possible only with sequencing-based methods.
              AVAILABILITY AND IMPLEMENTATION:
              http://bioconductor.org/packages/release/bioc/html/minfi.html.
              CONTACT: khansen@jhsph.edu; rafa@jimmy.harvard.edu SUPPLEMENTARY
              INFORMATION: Supplementary data are available at Bioinformatics
              online.",
  journal  = "Bioinformatics",
  volume   =  30,
  number   =  10,
  pages    = "1363--1369",
  month    =  may,
  year     =  2014,
  language = "en"
}

@ARTICLE{Armstrong2017-vg,
  title    = "Aging, exceptional longevity and comparisons of the Hannum and
              Horvath epigenetic clocks",
  author   = "Armstrong, Nicola J and Mather, Karen A and Thalamuthu, Anbupalam
              and Wright, Margaret J and Trollor, Julian N and Ames, David and
              Brodaty, Henry and Schofield, Peter R and Sachdev, Perminder S
              and Kwok, John B",
  abstract = "AIM: To examine the relationships between two epigenetic clocks,
              aging and exceptional longevity. MATERIALS \& METHODS:
              Participants were from three adult cohorts with blood DNA
              methylation data (Illumina 450 K, n = 275, 34-103 years).
              Epigenetic age (DNAmage) and age acceleration measures were
              calculated using the Hannum and Horvath epigenetic clocks.
              RESULTS: Across all cohorts, DNAmage was correlated with
              chronological age. In the long-lived cohort (Sydney Centenarian
              Study; 95+, n = 23), DNAmage was lower than chronological age for
              both clocks. Mean Sydney Centenarian Study Hannum age
              acceleration was negative, while the converse was observed for
              the Horvath model. CONCLUSION: Long-lived individuals have a
              young epigenetic age compared with their chronological age.",
  journal  = "Epigenomics",
  volume   =  9,
  number   =  5,
  pages    = "689--700",
  month    =  may,
  year     =  2017,
  keywords = "DNAmage; acceleration; age; aging; centenarians; epigenetic
              clock; longevity",
  language = "en"
}

@ARTICLE{Horvath2018-ia,
  title    = "{DNA} methylation-based biomarkers and the epigenetic clock
              theory of ageing",
  author   = "Horvath, Steve and Raj, Kenneth",
  abstract = "Identifying and validating molecular targets of interventions
              that extend the human health span and lifespan has been
              difficult, as most clinical biomarkers are not sufficiently
              representative of the fundamental mechanisms of ageing to serve
              as their indicators. In a recent breakthrough, biomarkers of
              ageing based on DNA methylation data have enabled accurate age
              estimates for any tissue across the entire life course. These
              'epigenetic clocks' link developmental and maintenance processes
              to biological ageing, giving rise to a unified theory of life
              course. Epigenetic biomarkers may help to address long-standing
              questions in many fields, including the central question: why do
              we age?",
  journal  = "Nat. Rev. Genet.",
  volume   =  19,
  number   =  6,
  pages    = "371--384",
  month    =  jun,
  year     =  2018,
  language = "en"
}

@UNPUBLISHED{Pinho2021-gm,
  title    = "Hibernation slows epigenetic aging in yellow-bellied marmots",
  author   = "Pinho, Gabriela M and Martin, Julien G A and Farrell, Colin and
              Haghani, Amin and Zoller, Joseph A and Zhang, Joshua and Snir,
              Sagi and Pellegrini, Matteo and Wayne, Robert K and Blumstein,
              Daniel T and Horvath, Steve",
  abstract = "Species that hibernate live longer than would be expected based
              solely on their body size. Hibernation is characterized by long
              periods of metabolic suppression (torpor) interspersed by short
              periods of increased metabolism (arousal). The torpor-arousal
              cycles occur multiple times during hibernation, and it has been
              suggested that processes controlling the transition between
              torpor and arousal states cause aging suppression. Metabolic rate
              is also a known correlate of longevity, we thus proposed the
              `hibernation-aging hypothesis' whereby aging is suspended during
              hibernation. We tested this hypothesis in a well-studied
              population of yellow-bellied marmots ( Marmota flaviventer ),
              which spend 7-8 months per year hibernating. We used two
              approaches to estimate epigenetic age: the epigenetic clock and
              the epigenetic pacemaker. Variation in epigenetic age of 149
              samples collected throughout the life of 73 females were modeled
              using generalized additive mixed models (GAMM), where season
              (cyclic cubic spline) and chronological age (cubic spline) were
              fixed effects. As expected, the GAMM using epigenetic ages
              calculated from the epigenetic pacemaker was better able to
              detect nonlinear patterns in epigenetic age change over time. We
              observed a logarithmic curve of epigenetic age with time, where
              the epigenetic age increased at a higher rate until females
              reached sexual maturity (2-years old). With respect to circannual
              patterns, the epigenetic age increased during the summer and
              essentially stalled during the winter. Our enrichment analysis of
              age-related CpG sites revealed pathways related to development
              and cell differentiation, while the season-related CpGs enriched
              pathways related to central carbon metabolism, immune system, and
              circadian clock. Taken together, our results are consistent with
              the hibernation-aging hypothesis and may explain the enhanced
              longevity in hibernators. \#\#\# Competing Interest Statement SH
              is a founder of the non-profit Epigenetic Clock Development
              Foundation which plans to license several patents from his
              employer UC Regents. These patents list SH as inventor. The other
              authors declare no conflicts of interest.",
  journal  = "Cold Spring Harbor Laboratory",
  pages    = "2021.03.07.434299",
  month    =  mar,
  year     =  2021,
  language = "en"
}

@ARTICLE{Demetriou2013-jx,
  title    = "Methylome analysis and epigenetic changes associated with
              menarcheal age",
  author   = "Demetriou, Christiana A and Chen, Jia and Polidoro, Silvia and
              van Veldhoven, Karin and Cuenin, Cyrille and Campanella, Gianluca
              and Brennan, Kevin and Clavel-Chapelon, Fran{\c c}oise and
              Dossus, Laure and Kvaskoff, Marina and Drogan, Dagmar and Boeing,
              Heiner and Kaaks, Rudolf and Risch, Angela and Trichopoulos,
              Dimitrios and Lagiou, Pagona and Masala, Giovanna and Sieri,
              Sabina and Tumino, Rosario and Panico, Salvatore and Quir{\'o}s,
              J Ram{\'o}n and S{\'a}nchez Perez, Mar{\'\i}a-Jos{\'e} and
              Amiano, Pilar and Huerta Casta{\~n}o, Jos{\'e} Mar{\'\i}a and
              Ardanaz, Eva and Onland-Moret, Charlotte and Peeters, Petra and
              Khaw, Kay-Tee and Wareham, Nick and Key, Timothy J and Travis,
              Ruth C and Romieu, Isabelle and Gallo, Valentina and Gunter, Marc
              and Herceg, Zdenko and Kyriacou, Kyriacos and Riboli, Elio and
              Flanagan, James M and Vineis, Paolo",
  abstract = "Reproductive factors have been linked to both breast cancer and
              DNA methylation, suggesting methylation as an important mechanism
              by which reproductive factors impact on disease risk. However,
              few studies have investigated the link between reproductive
              factors and DNA methylation in humans. Genome-wide methylation in
              peripheral blood lymphocytes of 376 healthy women from the
              prospective EPIC study was investigated using LUminometric
              Methylation Assay (LUMA). Also, methylation of 458877 CpG sites
              was additionally investigated in an independent group of 332
              participants of the EPIC-Italy sub-cohort, using the Infinium
              HumanMethylation 450 BeadChip. Multivariate logistic regression
              and linear models were used to investigate the association
              between reproductive risk factors and genome wide and
              CpG-specific DNA methylation, respectively. Menarcheal age was
              inversely associated with global DNA methylation as measured with
              LUMA. For each yearly increase in age at menarche, the risk of
              having genome wide methylation below median level was increased
              by 32\% (OR:1.32, 95\%CI:1.14-1.53). When age at menarche was
              treated as a categorical variable, there was an inverse
              dose-response relationship with LUMA methylation levels (OR(12-14
              vs. $\leq$11 yrs):1.78, 95\%CI:1.01-3.17 and OR($\geq$15 vs.
              $\leq$11 yrs):4.59, 95\%CI:2.04-10.33; P for trend<0.0001).
              However, average levels of global methylation as measured by the
              Illumina technology were not significantly associated with
              menarcheal age. In locus by locus comparative analyses, only one
              CpG site had significantly different methylation depending on the
              menarcheal age category examined, but this finding was not
              replicated by pyrosequencing in an independent data set. This
              study suggests a link between age at menarche and genome wide DNA
              methylation, and the difference in results between the two arrays
              suggests that repetitive element methylation has a role in the
              association. Epigenetic changes may be modulated by menarcheal
              age, or the association may be a mirror of other important
              changes in early life that have a detectable effect on both
              methylation levels and menarcheal age.",
  journal  = "PLoS One",
  volume   =  8,
  number   =  11,
  pages    = "e79391",
  month    =  nov,
  year     =  2013,
  language = "en"
}

@ARTICLE{Johnson2020-vb,
  title    = "Longitudinal {DNA} methylation differences precede type 1
              diabetes",
  author   = "Johnson, Randi K and Vanderlinden, Lauren A and Dong, Fran and
              Carry, Patrick M and Seifert, Jennifer and Waugh, Kathleen and
              Shorrosh, Hanan and Fingerlin, Tasha and Frohnert, Brigitte I and
              Yang, Ivana V and Kechris, Katerina and Rewers, Marian and
              Norris, Jill M",
  abstract = "DNA methylation may be involved in development of type 1 diabetes
              (T1D), but previous epigenome-wide association studies were
              conducted among cases with clinically diagnosed diabetes. Using
              multiple pre-disease peripheral blood samples on the Illumina 450
              K and EPIC platforms, we investigated longitudinal methylation
              differences between 87 T1D cases and 87 controls from the
              prospective Diabetes Autoimmunity Study in the Young (DAISY)
              cohort. Change in methylation with age differed between cases and
              controls in 10 regions. Average longitudinal methylation differed
              between cases and controls at two genomic positions and 28
              regions. Some methylation differences were detectable and
              consistent as early as birth, including before and after the
              onset of preclinical islet autoimmunity. Results map to
              transcription factors, other protein coding genes, and non-coding
              regions of the genome with regulatory potential. The
              identification of methylation differences that predate islet
              autoimmunity and clinical diagnosis may suggest a role for
              epigenetics in T1D pathogenesis; however, functional validation
              is warranted.",
  journal  = "Sci. Rep.",
  volume   =  10,
  number   =  1,
  pages    = "3721",
  month    =  feb,
  year     =  2020,
  language = "en"
}

@ARTICLE{Hoque1998-so,
  title    = "Cancer among a Michigan cohort exposed to polybrominated
              biphenyls in 1973",
  author   = "Hoque, A and Sigurdson, A J and Burau, K D and Humphrey, H E and
              Hess, K R and Sweeney, A M",
  abstract = "The long-term health effects of human exposure to polybrominated
              biphenyls are not known. In this nested case-control study, we
              evaluated the association between site-specific cancer risk and
              serum polybrominated biphenyl levels among a Michigan cohort
              accidentally exposed to polybrominated biphenyls in 1973. The
              Michigan Department of Public Health has followed 3,899 people
              through 1993, among whom 195 primary cancers were identified in
              187 persons. Controls were 696 randomly selected cancer-free
              individuals who were frequency matched to cases by sex and age
              (in 5-year strata). Baseline serum polybrominated biphenyl levels
              were measured using standard methods. We found an increasing
              dose-response relation for digestive system cancer risk with
              higher serum polybrominated biphenyl category [4-20 parts per
              billion (ppb), 21-50 ppb, and > 50 ppb] after adjustment for age,
              family cancer history, cigarette smoking, alcohol drinking, and
              baseline serum polychlorinated biphenyl level. Adjusted odds
              ratios (ORs) for each category were 8.23 [95\% confidence
              interval (CI) = 1.27-53.3], 12.3 (95\% CI = 0.80-191), and 22.9
              (95\% CI = 1.34-392), respectively. Univariate analysis for
              polybrominated biphenyl level and lymphoma risk also showed a
              dose-response relation, with corresponding ORs of 3.24 (95\% CI =
              0.24-95.9), 20.5 (95\% CI = 1.51-608), and 32.6 (95\% CI =
              3.33-861).",
  journal  = "Epidemiology",
  volume   =  9,
  number   =  4,
  pages    = "373--378",
  month    =  jul,
  year     =  1998,
  language = "en"
}

@ARTICLE{Fries1985-nf,
  title    = "The {PBB} episode in Michigan: an overall appraisal",
  author   = "Fries, G F",
  abstract = "Polybrominated biphenyls (PBB) were used as a fire retardant. In
              common with other halogenated hydrocarbons, PBBs are lipophilic
              and resistant to chemical and metabolic degradation. Cattle on
              about 25 Michigan farms were exposed to as much as 250 g per head
              of PBB when it was accidentally mixed in cattle feed in 1973 to
              1974. Livestock exposures several orders of magnitude lower
              occurred on several hundred other farms because of carryover and
              equipment contamination in feed mills. Approximately 85\% of the
              Michigan population received some exposure to PBB because dairy
              product marketing involves mixing milk from many farms. A few
              cases of high human exposure, which may have been as great as 10
              g, occurred when residents of the more highly exposed farms
              consumed their own products. Although numerous clinical signs and
              pathological changes were reported in exposed cattle, only
              anorexia, lacrimation, emaciation, hyperkeratosis, and kidney
              damage were confirmed in controlled studies. The acute toxicity
              of PBB in laboratory animals is low, but a variety of subacute
              effects have been reported. Induction of microsomal enzymes,
              enlargement and histopathological changes of the liver,
              fetotoxicity, and immunosuppression are among the more
              significant. Epidemiological studies of exposed humans have
              revealed no pattern of clinical signs or symptoms that were
              related to PBB exposure. A complete evaluation of the human
              consequences of exposure to PBB await the conclusion of long-term
              epidemiological studies.",
  journal  = "Crit. Rev. Toxicol.",
  volume   =  16,
  number   =  2,
  pages    = "105--156",
  year     =  1985,
  language = "en"
}

@ARTICLE{Horvath2015-af,
  title    = "Increased epigenetic age and granulocyte counts in the blood of
              Parkinson's disease patients",
  author   = "Horvath, Steve and Ritz, Beate R",
  abstract = "It has been a long standing hypothesis that blood tissue of PD
              Parkinson's disease (PD) patients may exhibit signs of
              accelerated aging. Here we use DNA methylation based biomarkers
              of aging (``epigenetic clock'') to assess the aging rate of blood
              in two ethnically distinct case-control data sets. Using n=508
              Caucasian and n=84 Hispanic blood samples, we assess a) the
              intrinsic epigenetic age acceleration of blood (IEAA), which is
              independent of blood cell counts, and b) the extrinsic epigenetic
              age acceleration rate of blood (EEAA) which is associated with
              age dependent changes in blood cell counts. Blood of PD subjects
              exhibits increased age acceleration according to both IEAA
              (p=0.019) and EEAA (p=6.1 x 10(-3)). We find striking differences
              in imputed blood cell counts between PD cases and controls.
              Compared to control subjects, PD subjects contains more
              granulocytes (p=1.0 x 10(-9) in Caucasians, p=0.00066 in
              Hispanics) but fewer T helper cells (p=1.4 x 10(-6) in
              Caucasians, p=0.0024 in Hispanics) and fewer B cells (p=1.6 x
              10(-5) in Caucasians, p=4.5 x 10(-5) in Hispanics). Overall, this
              study shows that the epigenetic age of the immune system is
              significantly increased in PD patients and that granulocytes play
              a significant role.",
  journal  = "Aging",
  volume   =  7,
  number   =  12,
  pages    = "1130--1142",
  month    =  dec,
  year     =  2015,
  keywords = "DNA methylation; Parkinson's disease; epigenetic clock;
              epigenetics; granulocyte; neutrophil",
  language = "en"
}

@ARTICLE{Triche2013-pp,
  title    = "Low-level processing of Illumina Infinium {DNA} Methylation
              {BeadArrays}",
  author   = "Triche, Jr, Timothy J and Weisenberger, Daniel J and Van Den
              Berg, David and Laird, Peter W and Siegmund, Kimberly D",
  abstract = "We propose a novel approach to background correction for Infinium
              HumanMethylation data to account for technical variation in
              background fluorescence signal. Our approach capitalizes on a new
              use for the Infinium I design bead types to measure non-specific
              fluorescence in the colour channel opposite of their design
              (Cy3/Cy5). This provides tens of thousands of features for
              measuring background instead of the much smaller number of
              negative control probes on the platforms (n = 32 for
              HumanMethylation27 and n = 614 for HumanMethylation450,
              respectively). We compare the performance of our methods with
              existing approaches, using technical replicates of both mixture
              samples and biological samples, and demonstrate that within- and
              between-platform artefacts can be substantially reduced, with
              concomitant improvement in sensitivity, by the proposed methods.",
  journal  = "Nucleic Acids Res.",
  volume   =  41,
  number   =  7,
  pages    = "e90",
  month    =  apr,
  year     =  2013,
  language = "en"
}

@ARTICLE{Waskom2021-gj,
  title     = "seaborn: statistical data visualization",
  author    = "Waskom, Michael",
  journal   = "J. Open Source Softw.",
  publisher = "The Open Journal",
  volume    =  6,
  number    =  60,
  pages     = "3021",
  month     =  apr,
  year      =  2021,
  copyright = "http://creativecommons.org/licenses/by/4.0/"
}

@ARTICLE{Horvath2015-wm,
  title    = "Decreased epigenetic age of {PBMCs} from Italian
              semi-supercentenarians and their offspring",
  author   = "Horvath, Steve and Pirazzini, Chiara and Bacalini, Maria Giulia
              and Gentilini, Davide and Di Blasio, Anna Maria and Delledonne,
              Massimo and Mari, Daniela and Arosio, Beatrice and Monti, Daniela
              and Passarino, Giuseppe and De Rango, Francesco and D'Aquila,
              Patrizia and Giuliani, Cristina and Marasco, Elena and Collino,
              Sebastiano and Descombes, Patrick and Garagnani, Paolo and
              Franceschi, Claudio",
  abstract = "Given the dramatic increase in ageing populations, it is of great
              importance to understand the genetic and molecular determinants
              of healthy ageing and longevity. Semi-supercentenarians (subjects
              who reached an age of 105-109 years) arguably represent the gold
              standard of successful human ageing because they managed to avoid
              or postpone the onset of major age-related diseases. Relatively
              few studies have looked at epigenetic determinants of extreme
              longevity in humans. Here we test whether families with extreme
              longevity are epigenetically distinct from controls according to
              an epigenetic biomarker of ageing which is known as ``epigenetic
              clock''. We analyze the DNA methylation levels of peripheral
              blood mononuclear cells (PBMCs) from Italian families constituted
              of 82 semi-supercentenarians (mean age: 105.6 $\pm$ 1.6 years),
              63 semi-supercentenarians' offspring (mean age: 71.8 $\pm$ 7.8
              years), and 47 age-matched controls (mean age: 69.8 $\pm$ 7.2
              years). We demonstrate that the offspring of
              semi-supercentenarians have a lower epigenetic age than
              age-matched controls (age difference=5.1 years, p=0.00043) and
              that centenarians are younger (8.6 years) than expected based on
              their chronological age. By contrast, no significant difference
              could be observed for estimated blood cell counts (such as
              na{\"\i}ve or exhausted cytotoxic T cells or helper T cells).
              Future studies will be needed to replicate these findings in
              different populations and to extend them to other tissues.
              Overall, our results suggest that epigenetic processes might play
              a role in extreme longevity and healthy human ageing.",
  journal  = "Aging",
  volume   =  7,
  number   =  12,
  pages    = "1159--1170",
  month    =  dec,
  year     =  2015,
  keywords = "DNA methylation; biomarker of ageing; epigenetic clock;
              semi-supercentenarians; semi-supercentenarians offspring",
  language = "en"
}

@ARTICLE{Snir2016-dv,
  title    = "A Statistical Framework to Identify Deviation from Time Linearity
              in Epigenetic Aging",
  author   = "Snir, Sagi and vonHoldt, Bridgett M and Pellegrini, Matteo",
  abstract = "In multiple studies DNA methylation has proven to be an accurate
              biomarker of age. To develop these biomarkers, the methylation of
              multiple CpG sites is typically linearly combined to predict
              chronological age. By contrast, in this study we apply the
              Universal PaceMaker (UPM) model to investigate changes in DNA
              methylation during aging. The UPM was initially developed to
              study rate acceleration/deceleration in sequence evolution.
              Rather than identifying which linear combinations of sites
              predicts age, the UPM models the rates of change of multiple CpG
              sites, as well as their starting methylation levels, and
              estimates the age of each individual to optimize the model fit.
              We refer to the estimated age as the ``epigenetic age'', which is
              in contrast to the known chronological age of each individual. We
              construct a statistical framework and devise an algorithm to
              determine whether a genomic pacemaker is in effect (i.e rates of
              change vary with age). The decision is made by comparing two
              competing likelihood based models, the molecular clock (MC) and
              UPM. For the molecular clock model, we use the known
              chronological age of each individual and fit the methylation
              rates at multiple sites, and express the problem as a linear
              least squares and solve it in polynomial time. For the UPM case,
              the search space is larger as we are fitting both the epigenetic
              age of each individual as well as the rates for each site, yet we
              succeed to reduce the problem to the space of individuals and
              polynomial in the more significant space-the methylated sites. We
              first tested our algorithm on simulated data to elucidate the
              factors affecting the identification of the pacemaker model. We
              find that, provided with enough data, our algorithm is capable of
              identifying a pacemaker even when a weak signal is present in the
              data. Based on these results, we applied our method to DNA
              methylation data from human blood from individuals of various
              ages. Although the improvement in variance across sites between
              the UPM and MC was small, the results suggest that the existence
              of a pacemaker is highly significant. The PaceMaker results also
              suggest a decay in the rate of change in DNA methylation with
              age.",
  journal  = "PLoS Comput. Biol.",
  volume   =  12,
  number   =  11,
  pages    = "e1005183",
  month    =  nov,
  year     =  2016,
  language = "en"
}
